Discontinued — last reported Q1 '26

Products & Services · Sales

Companion Animals — Sales

Merck & Co. Companion Animals — Sales decreased by 29.7% to $727.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $1.33B to $727.00M. Over 4 years (FY 2021 to FY 2025), Companion Animals — Sales shows relatively stable performance with a 2.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests growing market share or higher demand for pet healthcare products, while a decrease may indicate increased competition or a slowdown in consumer spending on veterinary care.

Detailed definition

This metric represents the total revenue generated from the sale of pharmaceutical products, vaccines, and health soluti...

Peer comparison

Comparable to animal health revenue segments at companies like Zoetis or Elanco, typically benchmarked against overall pet care industry growth rates.

Metric ID: mrk_segment_companion_animal_sales

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.30B$1.11B$940.00M$1.30B$1.28B$1.08B$834.00M$1.28B$1.30B$1.05B$942.00M$1.32B$1.29B$1.20B$1.02B$1.33B$1.37B$1.18B$1.03B$727.00M
QoQ Change-15.1%-15.0%+38.3%-1.4%-15.4%-23.1%+54.0%+1.1%-19.0%-10.5%+40.4%-2.5%-6.9%-15.3%+30.6%+3.2%-13.6%-12.7%-29.7%
YoY Change-1.5%-2.0%-11.3%-1.2%+1.2%-3.0%+12.9%+3.0%-0.6%+14.2%+8.0%+0.4%+6.2%-1.4%+1.7%-45.3%
Range$727.00M$1.37B
CAGR-11.5%
Avg YoY Growth-1.2%
Median YoY Growth-0.1%
Current Streak3 quarters decline

Frequently Asked Questions

What is Merck & Co.'s companion animals — sales?
Merck & Co. (MRK) reported companion animals — sales of $727.00M in Q1 2026.
How has Merck & Co.'s companion animals — sales changed year-over-year?
Merck & Co.'s companion animals — sales decreased by 45.3% year-over-year, from $1.33B to $727.00M.
What is the long-term trend for Merck & Co.'s companion animals — sales?
Over 4 years (2021 to 2025), Merck & Co.'s companion animals — sales has grown at a 2.0% compound annual growth rate (CAGR), from $4.55B to $4.92B.
What does companion animals — sales mean?
The total revenue earned from selling health products and medicines for household pets.